Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125354601 | 12535460 | 1 | I | 20160624 | 20160707 | 20160707 | EXP | TR-MLMSERVICE-20160621-0287504-1 | TR-ACCORD-042064 | ACCORD | GOKCE E, BEYHAN M, ACU B. EVALUATION OF ORAL ANTICOAGULANT-ASSOCIATED INTRACRANIAL PARENCHYMAL HEMATOMAS USING CT FINDINGS.CLINICAL NEURORADIOLOGY. 2015; 25(2):151-159. | 0.00 | Y | 0.00000 | 20160707 | MD | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125354601 | 12535460 | 1 | PS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 202925 | ||||||||||||
| 125354601 | 12535460 | 2 | SS | WARFARIN | WARFARIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125354601 | 12535460 | 1 | Anticoagulant therapy |
| 125354601 | 12535460 | 2 | Anticoagulant therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125354601 | 12535460 | OT |
| 125354601 | 12535460 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125354601 | 12535460 | Haematoma | |
| 125354601 | 12535460 | Haemorrhage intracranial |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |